AU6872687A - Unsaturated amino acids - Google Patents

Unsaturated amino acids

Info

Publication number
AU6872687A
AU6872687A AU68726/87A AU6872687A AU6872687A AU 6872687 A AU6872687 A AU 6872687A AU 68726/87 A AU68726/87 A AU 68726/87A AU 6872687 A AU6872687 A AU 6872687A AU 6872687 A AU6872687 A AU 6872687A
Authority
AU
Australia
Prior art keywords
alkyl
amino
hydroxy
phosphono
pentenoic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU68726/87A
Other versions
AU610493B2 (en
Inventor
Christof Angst
Derek Edward Brundish
John Grey Dingwall
Graham Eric Fagg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU6872687A publication Critical patent/AU6872687A/en
Application granted granted Critical
Publication of AU610493B2 publication Critical patent/AU610493B2/en
Assigned to NOVARTIS AG reassignment NOVARTIS AG Request to Amend Deed and Register Assignors: CIBA-GEIGY AG
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3826—Acyclic unsaturated acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
    • C07F9/302—Acyclic unsaturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
    • C07F9/32—Esters thereof
    • C07F9/3205—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3217—Esters of acyclic unsaturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4015—Esters of acyclic unsaturated acids

Abstract

Phosphorus-contg. unsaturated amino acids of formula (I) and their salts are new: R1 = hydroxy or etherified hydroxy; R2 = H, alkyl, hydroxy or etherified hydroxy; R3 = H, alkyl, haloalkyl, hydroxyalkyl, lower alkoxyalkyl, arylalkyl, lower alkenyl, halogen or aryl; R4 = H, alkyl or arl; R5 = H or alkyl; R6 = carboxy or esterified or amidated carboxy; R7 0 amino opt. substd. by alkyl or aryl; A = opt. alkyl-substd. 1-3C alpha, omega-alkylene or a direct bond; B = methyleue or direct bond; provided that A and B are both direct bonds. Specifically claimed are 9 cpds. including E-2-amino-5- phosphono-3-pentenoic acid, E-2-amino-4-methyl-5-phosphono -3-pentenoic acid, and E-2-amino-4-methyl -5-phosphono-3-pentenoic acid ethyl ester.
AU68726/87A 1986-02-13 1987-02-12 Unsaturated amino acids Ceased AU610493B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH57886 1986-02-13
CH578/86 1986-02-13

Publications (2)

Publication Number Publication Date
AU6872687A true AU6872687A (en) 1987-08-20
AU610493B2 AU610493B2 (en) 1991-05-23

Family

ID=4190244

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68726/87A Ceased AU610493B2 (en) 1986-02-13 1987-02-12 Unsaturated amino acids

Country Status (23)

Country Link
EP (1) EP0233154B1 (en)
JP (2) JPH0717665B2 (en)
KR (1) KR900003533B1 (en)
AT (1) ATE70535T1 (en)
AU (1) AU610493B2 (en)
CA (1) CA1331625C (en)
CY (1) CY1821A (en)
DD (1) DD263775A5 (en)
DE (1) DE3775229D1 (en)
DK (1) DK169341B1 (en)
ES (1) ES2038690T3 (en)
FI (1) FI85144C (en)
GR (1) GR3003526T3 (en)
HK (1) HK95594A (en)
HU (1) HU204532B (en)
IE (1) IE59417B1 (en)
IL (1) IL81543A0 (en)
NO (1) NO170938C (en)
NZ (1) NZ219255A (en)
PH (1) PH23762A (en)
PT (1) PT84270B (en)
SG (1) SG92294G (en)
ZA (1) ZA871022B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU605340B2 (en) * 1987-08-04 1991-01-10 Novartis Ag A process for the manufacture of novel unsaturated amino acid compounds
AU638057B2 (en) * 1989-09-26 1993-06-17 Novartis Ag 4-substituted 2-aminoalk-3-enoic acids

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175344A (en) * 1986-02-13 1992-12-29 Ciba-Geigy Corporation Unsaturated amino acids
PT85874B (en) * 1986-10-09 1990-07-31 Ciba Geigy Ag PROCESS FOR THE PREPARATION OF OLIGO-PEPTIDES WITH ANTIBIOTIC ACTION
US5175153A (en) * 1987-11-30 1992-12-29 Warner-Lambert Company Substituted alpha-amino acids having pharmaceutical activity
US5179085A (en) * 1989-03-15 1993-01-12 Warner-Lambert Company N-substituted α-amino acids and derivatives thereof having pharmaceutical activity
ATE112282T1 (en) * 1989-04-07 1994-10-15 Ciba Geigy Ag UNSATURATED AMINODICARBONIC ACID DERIVATIVES.
US5500419A (en) * 1989-09-19 1996-03-19 Merrell Dow Pharmaceuticals Inc. NMDA antagonists
US5294734A (en) * 1989-09-26 1994-03-15 Ciba-Geigy Corp. 4-substituted 2-aminoalk-3-enoic acids
US5488140A (en) * 1989-09-26 1996-01-30 Ciba-Geigy Corporation 4-substituted 2-aminoalk-3-enoic
US5238958A (en) * 1990-02-26 1993-08-24 Warner-Lambert Company Substituted α-amino acids having selected acidic moieties for use as excitatory amino acid antagonists in pharmaceuticals
JPH07505908A (en) * 1992-09-28 1995-06-29 マックセチーニ、マリア　ルイザ Allosteric modulator of NMDA receptor
AU2006310177A1 (en) * 2005-10-18 2007-05-10 Centre National De La Recherche Scientifique (Cnrs) Hypophosphorous acid derivatives and their therapeutical applications
DE102007032669A1 (en) * 2007-07-13 2009-01-15 Clariant International Limited Alkylphosphonous acids, salts and esters, process for their preparation and their use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5387314A (en) * 1977-01-07 1978-08-01 Heiichi Sakai Nn14099substance
US4477391A (en) * 1981-08-14 1984-10-16 Collins James F Amino acid isomers, their production and their medicinal use
GB2104079B (en) * 1981-08-14 1985-08-21 London Polytech New aminoacid isomers, their production and their medicinal use

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU605340B2 (en) * 1987-08-04 1991-01-10 Novartis Ag A process for the manufacture of novel unsaturated amino acid compounds
AU638057B2 (en) * 1989-09-26 1993-06-17 Novartis Ag 4-substituted 2-aminoalk-3-enoic acids

Also Published As

Publication number Publication date
FI85144B (en) 1991-11-29
ATE70535T1 (en) 1992-01-15
JPS62246586A (en) 1987-10-27
NO170938B (en) 1992-09-21
PH23762A (en) 1989-11-03
JP2509465B2 (en) 1996-06-19
CY1821A (en) 1995-10-20
PT84270A (en) 1987-03-01
SG92294G (en) 1995-04-28
CA1331625C (en) 1994-08-23
HU204532B (en) 1992-01-28
KR870007942A (en) 1987-09-23
AU610493B2 (en) 1991-05-23
PT84270B (en) 1989-09-14
EP0233154A2 (en) 1987-08-19
FI85144C (en) 1992-03-10
ES2038690T3 (en) 1993-08-01
NZ219255A (en) 1989-08-29
KR900003533B1 (en) 1990-05-21
DE3775229D1 (en) 1992-01-30
IE59417B1 (en) 1994-02-23
HUT43863A (en) 1987-12-28
DK169341B1 (en) 1994-10-10
JPH0717665B2 (en) 1995-03-01
DK70787A (en) 1987-08-14
IE870365L (en) 1987-08-13
FI870558A0 (en) 1987-02-11
DD263775A5 (en) 1989-01-11
EP0233154B1 (en) 1991-12-18
NO870577L (en) 1987-08-14
NO870577D0 (en) 1987-02-13
HK95594A (en) 1994-09-16
DK70787D0 (en) 1987-02-12
IL81543A0 (en) 1987-09-16
GR3003526T3 (en) 1993-03-16
JPH07206683A (en) 1995-08-08
EP0233154A3 (en) 1989-06-14
ZA871022B (en) 1987-09-30
FI870558A (en) 1987-08-14
NO170938C (en) 1992-12-30

Similar Documents

Publication Publication Date Title
AU6872687A (en) Unsaturated amino acids
EE9900535A (en) Use of fumaric acid derivatives
DE69633398D1 (en) BETULINIC ACID DERIVATIVES AND THEIR USE
ES2057126T3 (en) TREATMENT METHOD OF CAQUEXIA AND SOME NEW COMPOUNDS TO USE IN THIS METHOD.
ES2058173T3 (en) DIOXIALQUILENARIL-DIHIDROPIRIDINAS, INTERMEDIATE PRODUCTS FOR ITS MANUFACTURE, PROCEDURES FOR ITS MANUFACTURE AND ITS USE.
FI853254A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA STEROIDER, VILKA AER SUBSTITUERADE I 10-STAELLNINGEN MED EN RADIKAL INNEHAOLLANDE EN DUBBEL- ELLER TREDUBBELBINDNING.
TW355709B (en) Quinoline carboxylic acid derivative
ZA873721B (en) Substituted 6-hydroxymethyl-carbapenem antibiotics,a process for the preparation thereof,and the use thereof
DE59506873D1 (en) Process for the production of optically active L-amino acids
ATE32715T1 (en) PROCESS FOR THE PREPARATION OF B-((2METHYLPROPOXY)-METHYL>-N-PHENYL-N-(PHENYLMETHYL - 1-PYRROLIDINETHANAMINE.
GB1369577A (en) Indole-carboxylic acid derivatives
TW334437B (en) Process for the preparation of streptogramins
FI870057A (en) NYA TYRONINDERIVAT.
ES8107158A1 (en) Purification of L-aspartyl-L-phenylalanine alkyl esters.
PT80187A (en) A process for the preparation of quinoline carboxylic acid derivatives
PT85581A (en) Process for the preparation of n-(s-3-alkylheptanoyl)-d-gamma-glutamyl-glycyl-d-alanine
FR2244489A1 (en) 3-Halo-4-heterocyclic substd.-phenylalkanoic acids - their esters and salts with antiinflammatory activity
HUT40100A (en) Process for producing quinolin-carboxylic acid derivatives
FR2442052A1 (en) Human glaucoma treatment with labetalol - which is an amino- and hydroxyalkyl substd. salicylamide